» Authors » Jean-Pierre Cazenave

Jean-Pierre Cazenave

Explore the profile of Jean-Pierre Cazenave including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 69
Citations 1236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohlmann P, Hechler B, Chafey P, Ravanat C, Isola H, Wiesel M, et al.
Transfusion . 2016 Jun; 56(9):2239-47. PMID: 27250038
Background: The INTERCEPT Blood System (IBS) using amotosalen-HCl and ultraviolet (UV)A inactivates a large spectrum of microbial pathogens and white blood cells in therapeutic plasma. Our aim was to evaluate...
2.
Donnet T, Ravanat C, Eckly A, Maurer E, Alame G, Ziessel C, et al.
Transfusion . 2015 Apr; 55(9):2207-18. PMID: 25856501
Background: Platelets (PLTs) are currently stored at room temperature (RT) for 5 to 7 days. So far, there exists no validated method for the preparation and long-term storage of dehydrated...
3.
Cazenave J
Bull Acad Natl Med . 2014 Jun; 197(2):419-23. PMID: 24919371
No abstract available.
4.
Prudent M, DAlessandro A, Cazenave J, Devine D, Gachet C, Greinacher A, et al.
Transfus Med Rev . 2014 Apr; 28(2):72-83. PMID: 24685438
Pathogen inactivation (PI) of platelet concentrates (PCs) reduces the proliferation/replication of a large range of bacteria, viruses, and parasites as well as residual leucocytes. Pathogen-inactivated PCs were evaluated in various...
5.
Hechler B, Ohlmann P, Chafey P, Ravanat C, Eckly A, Maurer E, et al.
Transfusion . 2012 Oct; 53(6):1187-200. PMID: 23067365
Background: Platelet concentrate (PC) functionality decreases during storage. This is referred to as the storage lesion. Pathogen inactivation may accelerate or induce lesions, potentially accounting for reduced viability. Our aim...
6.
Lenormand C, Bausinger H, Gross F, Signorino-Gelo F, Koch S, Peressin M, et al.
J Immunol . 2012 Mar; 188(8):3903-11. PMID: 22407913
The precise role of human epidermal Langerhans cells (LCs) in immune response is highly controversial. While studying the gene expression profile of these cells, we were intrigued to identify the...
7.
Eckly A, Strassel C, Cazenave J, Lanza F, Leon C, Gachet C
Methods Mol Biol . 2011 Dec; 788:175-92. PMID: 22130708
Differentiation and maturation of megakaryocytes occur in close association with cellular and extracellular components in the bone marrow. Thus, direct examination of these processes in the native environment provides important...
8.
Gayol S, Kirchgesner T, Kopferschmitt J, Meyer N, Sauleau E, Wiesel M, et al.
Thromb Haemost . 2011 Nov; 107(1):184-7. PMID: 22116210
No abstract available.
9.
Cazenave J
Bull Acad Natl Med . 2011 Nov; 194(9):1707-19. PMID: 22043595
Transfusion of labile blood products (red cell concentrates, platelet concentrates and plasma) is vital in the absence of alternatives. Patients and doctors have always feared infections transmitted by blood, blood...
10.
Strassel C, Eckly A, Leon C, Moog S, Cazenave J, Gachet C, et al.
Exp Cell Res . 2011 Oct; 318(1):25-32. PMID: 22008103
Hematopoietic progenitors from murine fetal liver efficiently differentiate in culture into proplatelet-producing megakaryocytes and have proved valuable to study platelet biogenesis. In contrast, megakaryocyte maturation is far less efficient in...